Deerfield Management Company
Deerfield Management Company reported 67 stocks worth $5.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.5%), CNC (5.9%) and UTHR (5.7%). Compared with Q2 2026, the fund opened new positions in ZTS, COO and BLSM, added to UTHR, COGT and CELC, trimmed RVMD, VTRS and NAMS and sold out of LNTH, PFE and INDV.
Latest filing: what Deerfield Management Company did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() RVMD Revolution Medicines Inc | $436M | 8.5% | 2.1M | −268K (−11%) | 8 of 8 | |
| 2 | ![]() CNC Centene Corp Del | $304M | 5.9% | 4.9M | No change | 8 of 8 | |
| 3 | ![]() UTHR United Therapeutics Corp Del | $293M | 5.7% | 541K | +84K (+18%) | 7 of 8 | |
| 4 | ![]() PRAX Praxis Precision Medicines I | $281M | 5.5% | 963K | No change | 7 of 8 | |
| 5 | ![]() GMAB Genmab A/s | $245M | 4.8% | 6.9M | No change | 3 of 8 | |
| 6 | ![]() VTRS Viatris Inc | $194M | 3.8% | 10.9M | −9.3M (−46%) | 8 of 8 | |
| 7 | ![]() COGT Cogent Biosciences Inc | $191M | 3.7% | 6M | +951K (+19%) | 8 of 8 | |
| 8 | ![]() CELC Celcuity Inc | $191M | 3.7% | 2.4M | +947K (+65%) | 5 of 8 | |
| 9 | ![]() LEGN Legend Biotech Corp | $162M | 3.2% | 8.1M | No change | 8 of 8 | |
| 10 | ![]() VERA Vera Therapeutics Inc | $140M | 2.7% | 4.3M | +422K (+11%) | 7 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
NUVALENT INC | $2.1B | 17.2M |
![]() LNTH Lantheus Hldgs Inc | $83.5M | 753K |
![]() PFE Pfizer Inc | $73.2M | 3M |
![]() INDV Indivior PLC | $67.7M | 1.6M |
![]() CDNA Caredx Inc | $56.9M | 2M |
🔒 Free account: see all 12.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Deerfield Management Company 13F FAQ
What does Deerfield Management Company own?
Deerfield Management Company reported 67 stocks worth $5.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.5%), CNC (5.9%) and UTHR (5.7%). The table above lists every position in the filing (the top 10 without an account).
What did Deerfield Management Company buy and sell in Q3 2026?
Compared with Q2 2026: 7 new positions, 11 added to, 13 trimmed and 12 sold out. New positions include ZTS, COO and BLSM. It sold all of LNTH, PFE and INDV.
When will Deerfield Management Company file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Deerfield Management Company's portfolio worth?
The Q3 2026 filing reports $5.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.
























